Edgewise Therapeutics, Inc. 8-K

What Happened
Edgewise Therapeutics, Inc. (EWTX) announced its financial results for the fourth quarter and full year ended December 31, 2025 by issuing a press release on February 26, 2026. The full text of that press release is attached to the Form 8-K as Exhibit 99.1 and was furnished under Item 2.02 (Results of Operations and Financial Condition).

Key Details

• Filing date: February 26, 2026 (Form 8-K, Item 2.02).
• Reporting period: fourth quarter and full year ended December 31, 2025.
• Press release attached as Exhibit 99.1 and incorporated by reference in the Item 2.02 disclosure.
• Per Item 9.01, the information and Exhibit 99.1 are furnished (not “filed”) and are not subject to Section 18 liability or automatically incorporated by reference into other filings unless expressly stated.

Why It Matters
This 8-K notifies investors that Edgewise has publicly released its latest quarterly and annual financial results—key information for evaluating earnings, revenue trends, cash position, and company performance. Retail investors should review the attached press release (Exhibit 99.1) and any subsequent SEC filings for the specific financial figures, management commentary, and any forward-looking guidance. Note the filing’s legal disclaimer that the exhibit is furnished rather than filed, which affects incorporation and liability under the securities laws.